Wegovy side effects: what consumer reviews and clinical reports show

The decision most people reach before reading reviews

Before someone types "Wegovy side effects reviews" into a search engine, they have usually already decided they want to lose weight. The real question they are asking is: will I be able to tolerate this? That is a fair question, and if you want to go straight to what other patients have reported, our Wegovy side effects reviews page brings together those accounts in one place.

Clinical trial data gives one picture. The STEP 1 trial, published in the New England Journal of Medicine, recorded that gastrointestinal events were reported by around 74% of participants on semaglutide 2.4mg, compared with around 48% on placebo. That sounds alarming in isolation. The important detail is that the majority of those events were rated as mild or moderate, and most resolved as the body adjusted over days to a few weeks.

Consumer reviews add texture that trials cannot always capture. People describe the first four to eight weeks as the hardest, especially following each dose step up. Those who do well often credit slow titration and adjustments to when and what they eat. Those who stop early most commonly cite nausea severe enough to affect daily life or work. Neither experience is wrong. They reflect genuine variation in how people respond, and that variation is one reason clinical assessment before starting matters.

A question our prescribers hear most weeks is whether someone should push through the nausea or whether it signals that the medicine is not right for them. The honest answer is that it depends on the severity, the individual's history, and what dose they are on — which is exactly why that conversation belongs with a prescriber, not a forum.

The side effects that come up most often, and what the NHS data shows

The NHS medicines page for semaglutide lists the most common effects reported by people taking Wegovy. Nausea tends to top every list, both in trials and in consumer reports. Vomiting, diarrhoea, constipation, indigestion and burping follow closely. Fatigue, headache and dizziness are less frequently mentioned but real for some. Injection-site reactions, usually mild redness or itching, are reported by a smaller proportion.

A pattern that surprises many people is the relationship between dose increases and symptom flares. Settling at one dose for several weeks, then moving up, commonly triggers a short return of early symptoms. This is why the licensed titration schedule moves slowly, with roughly four weeks at each level. Rushing that process, which sometimes happens when people obtain medicines outside supervised care, is associated with worse tolerability.

Hair thinning appears in consumer reviews more often than the headline trial data might suggest. The current clinical view is that this is largely driven by the physiological stress of rapid weight loss rather than semaglutide directly. It tends to be temporary. For a fuller look at this specific concern, the hair loss and Wegovy page covers what the evidence actually shows.

Slightly less common effects include gallbladder-related symptoms and changes in heart rate. These appear at lower frequencies but are worth being aware of before starting.

When to get medical help, and what the MHRA's 2026 update flagged

Most side effects from Wegovy are uncomfortable rather than dangerous. A few require prompt medical attention.

Severe, persistent stomach pain that spreads towards the back, with or without vomiting, should be treated as a medical emergency. This symptom pattern can indicate acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting pancreatitis as an infrequent but serious risk. If this happens, stop taking the medicine and call 111 or 999 depending on severity.

Other situations that need medical review fairly quickly include: signs of an allergic reaction (rash, swelling, difficulty breathing); significant dehydration following repeated vomiting or diarrhoea; symptoms that suggest gallbladder problems such as severe upper-right abdominal pain; and any new or worsening low mood or thoughts of self-harm.

People sometimes worry about how to report something that feels minor. The answer is that you do not need to be certain. Suspected side effects (whether minor or serious) can be logged directly with the MHRA through the Yellow Card scheme at yellowcard.mhra.gov.uk. These reports genuinely shape how regulators monitor medicines after launch.

If you have started Wegovy through a prescriber and something does not feel right, contact your clinical team before stopping. Stopping abruptly does not cause harm, but advice on what to do next is better given by someone who knows your case.

What consumer reviews miss, and why supervised treatment changes the picture

Reading online reviews gives a useful sample, but a biased one. People who had severe side effects and stopped are often overrepresented, as are those who are very happy with results. The majority who had a manageable experience tend to post less. This does not mean the reviews are useless (they map the territory well) but it means they should be read as a range of possibilities, not a prediction.

The factor that most consistently appears in positive accounts is ongoing clinical support. Having somewhere to turn when nausea peaks at week three, or when a dose increase feels wrong, correlates with continuing treatment and reaching an effective dose. That is why the service model matters as much as the medicine itself. If you want to understand the full reported side-effect profile in more depth, or if you are wondering whether some people genuinely experience very few effects, our page on people with minimal side effects on Wegovy is worth reading alongside this one.

At nume, our prescribers discuss side effects, your health history and suitability as part of the free consultation, not as a box-ticking exercise, but because that conversation changes the plan. You can start your free consultation to speak with our clinical team, or read more about Wegovy side effects in detail before you decide.